Figure 2.

miR‐1258 inhibits NSCLC cell proliferation, angiogenesis and cell cycle progression. A, Compared with the control, Edu cell growth profiles in H1299 cells and SPCA1 cells after transfection with miR‐1258 and miR‐1258 inhibitor, respectively. B, CCK‐8 was used to determine the proliferation of transfected NSCLC cells. C, Effect of miR‐1258 expression on angiogenesis. D, The role of miR‐1258 in the recruitment of HUVECs. E, Effects of miR‐1258 alteration on cell cycle distribution of NSCLC cells. The data are represented as mean ± SD. (*P < .05; **P < .01; ***P < .001)